ImmunityBio (IBRX) Soars to New High on Anktiva Future Expansion

We recently published 10 Market Winners With Stunning Gains. Immunitybio Inc. (NASDAQ:IBRX) was one of the best performers on Wednesday. ImmunityBio soared to a new 52-week high on Wednesday, as investors gobbled up shares over an aggressive international expansion for its therapy, Anktiva. At intra-day trading, the stock climbed to its highest price of $8.68 before trimming gains to end the day just up by 41.86 percent at $8.54 apiece. In a statement, Immunitybio Inc. (NASDAQ:IBRX) said that the Europ ...